Aa. Poltera, FROM THE LABORATORY TO THE HOME OF THE PATIENT INFECTED WITH ONCHOCERCA-VOLVULUS (O-V) - CLINICAL-EXPERIENCE WITH AMOCARZINE (PRELIMINARY-RESULTS), Parasite, 1, 1994, pp. 25-27
if dosed correctly, amocarzine has onchocercacidal effects with accept
able clinical tolerobility. Up to now over 1 900 patients were exposed
to an initial amocarzine regimen and over 500 have been re-exposed to
amocarzine 2 years after initial therapy Amocarzine is a promising on
chocercacidal drug and a potential candidate for onchocerciasis contro
l programmes.